Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease

Published:2016 Issue:41 Volume:22 Page:9039
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Makri Evangelia,Cholongitas Evangelos,Tziomalos Konstantinos

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference38 articles.

1. Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview

2. Masarone M, Federico A, Abenavoli L, Loguercio C, Persico M. Non alcoholic fatty liver: epidemiology and natural history. Rev Recent Clin Trials 2014;9:126-133.

3. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground

4. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

5. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders;Saudi Journal of Gastroenterology;2024-05-06

2. Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease;Annals of Gastroenterology;2024

3. The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry;Diabetes, Metabolic Syndrome and Obesity;2023-10

4. Oligochitosan-based nanovesicles for nonalcoholic fatty liver disease treatment via the FXR/miR-34a/SIRT1 regulatory loop;Acta Biomaterialia;2023-07

5. Combination Therapies for Nonalcoholic Fatty Liver Disease;Journal of Personalized Medicine;2022-07-18